June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate (Pradaxa) anticoagulant oral pellets as the first oral anticoagulant to treat children ...
Deep Vein Thrombosis (DVT)
Deep vein thrombosis (DVT) is caused by the formation of venous blood clots in the arms and legs. This page includes information on technologies to treat DVT using catheter based interventions and thrombolysis.
October 31, 2023 — Results of four late-breaking clinical trials presented during the The VEINS Conference 2023, taking ...
November 21, 2022 — New research published in the Journal of the American College of Cardiology shows the use of drug ...
October 31, 2022 — Results from the Late-Breaking Clinical Trials session at The VEINS Conference in Las Vegas, NV, were ...

The global thrombectomy devices market is poised to experience substantial expansion, owing to the emergence of ...
May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin ...
January 10, 2022 – Akura Medical Inc., a Shifamed portfolio company, announced the closing of its $25 million Series A1 ...
June 21, 2021 — The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's dabigatran etexilate ...
Behnood Bikdeli M.D., a cardiologist at the Brigham and Women’s Hospital, Harvard Medical School, Boston, offers an ...

A comprehensive review or more than 80 randomized controlled trials (RCTs) investigating how to best manage optimal ...
January 8, 2021 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Inari Medical Inc ...

December 23, 2020 — Three clinical trial platforms working together to test the effects of full doses of anticoagulants ...
October 26, 2020 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic Abre venous self-expanding ...
September 11, 2020 — The National Institutes of Health (NIH) has launched two of three adaptive clinical trials ...

May 4, 2020 — A committee comprised of vascular surgeons, medical physicians and technologists from the University of ...